Literature DB >> 10753208

LacI mutation spectra following benzo[a]pyrene treatment of Big Blue mice.

B S Shane1, J de Boer, D E Watson, J K Haseman, B W Glickman, K R Tindall.   

Abstract

The mutation spectrum of the lacI gene from the liver of C57Bl6 Big Blue transgenic mice treated with benzo[a]pyrene (B[a]P) has been compared with the spectrum of spontaneous mutations observed in the liver of untreated Big Blue mice. Mice were treated with B[a]P for 3 days followed by a partial hepatectomy one day after the last injection. Liver tissue was removed for analysis at hepatectomy and, again, 3 days later at the time of sacrifice. Earlier, we reported that the lacI mutant frequency in these B[a]P-treated mice was elevated in the liver both at the time of hepatectomy and at sacrifice; however, a statistically significant increase in the mutant frequency was observed only at sacrifice. In this study, the DNA sequence spectra of lacI mutations observed in the liver of B[a]P-treated Big Blue mice at hepatectomy and at time of sacrifice were compared with each other and with the spectrum of spontaneous liver mutations. No differences were observed between the two B[a]P-treatment spectra. However, mutation frequencies of both GC-->TA and GC-->CG at the time of hepatectomy and at sacrifice were significantly elevated compared with the spontaneous frequency of these same transversions. Also, the frequency of AT-->TA transversions was significantly higher than the spontaneous frequency at the time of hepatectomy but not at sacrifice. The frequency of all other classes of mutations scored was not significantly different from the frequency of these same events in the spontaneous spectra. These data support the view that B[a]P treatment results in the induction of GC-->TA and GC-->CG transversions within 1 day of the last injection and they provide insights regarding the relative roles of benzo[a]pyrene-7,8-diol-9, 10-epoxide and radical cations of B[a]P in B[a]P-induced mutagenesis in vivo. Finally, these data provide evidence for B[a]P-induced mutagenesis under conditions where no statistical increase in mutant frequency could be shown.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753208     DOI: 10.1093/carcin/21.4.715

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

Review 1.  Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Authors:  Deacqunita L Diggs; Ashley C Huderson; Kelly L Harris; Jeremy N Myers; Leah D Banks; Perumalla V Rekhadevi; Mohammad S Niaz; Aramandla Ramesh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2011-10       Impact factor: 3.781

2.  The Lambda Select cII Mutation Detection System.

Authors:  Ahmad Besaratinia; Stella Tommasi
Journal:  J Vis Exp       Date:  2018-04-26       Impact factor: 1.355

3.  Environmental exposure of the mouse germ line: DNA adducts in spermatozoa and formation of de novo mutations during spermatogenesis.

Authors:  Ann-Karin Olsen; Ashild Andreassen; Rajinder Singh; Richard Wiger; Nur Duale; Peter B Farmer; Gunnar Brunborg
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

4.  Chronic Mycobacterium marinum infection acts as a tumor promoter in Japanese Medaka (Oryzias latipes).

Authors:  Gregory W Broussard; Michelle B Norris; Adam R Schwindt; John W Fournie; Richard N Winn; Michael L Kent; Don G Ennis
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2008-09-24       Impact factor: 3.228

5.  Polk mutant mice have a spontaneous mutator phenotype.

Authors:  J Nicole Kosarek Stancel; Lisa D McDaniel; Susana Velasco; James Richardson; Caixia Guo; Errol C Friedberg
Journal:  DNA Repair (Amst)       Date:  2009-09-26

6.  Mutagenicity of 3-methylcholanthrene, pcb3, and 4-oh-pcb3 in the lung of transgenic bigblue rats.

Authors:  Catherine Maddox; Bingxuan Wang; Patricia A Kirby; Kai Wang; Gabriele Ludewig
Journal:  Environ Toxicol Pharmacol       Date:  2008-03       Impact factor: 4.860

7.  Mutagenicity testing with transgenic mice. Part II: Comparison with the mouse spot test.

Authors:  Ulrich Wahnschaffe; Annette Bitsch; Janet Kielhorn; Inge Mangelsdorf
Journal:  J Carcinog       Date:  2005-01-27

8.  Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test.

Authors:  U Wahnschaffe; A Bitsch; J Kielhorn; I Mangelsdorf
Journal:  J Carcinog       Date:  2005-01-17

9.  Characterizing Benzo[a]pyrene-induced lacZ mutation spectrum in transgenic mice using next-generation sequencing.

Authors:  Marc A Beal; Rémi Gagné; Andrew Williams; Francesco Marchetti; Carole L Yauk
Journal:  BMC Genomics       Date:  2015-10-19       Impact factor: 3.969

10.  Early-life exposure to benzo[a]pyrene increases mutant frequency in spermatogenic cells in adulthood.

Authors:  Guogang Xu; C Alex McMahan; Christi A Walter
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.